JYNNEOS mpox vaccine distribution
Digital Health News

Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant expansion for access to JYNNEOS® by establishing additional pathways for vaccine procurement, distribution, and reimbursement by both public and private payers. Since 2022, in response to the global mpox outbreak, JYNNEOS has […]

Prof. Raj Kumar receiving the ATS Public Service Award at the ATS 2024 International Conference
Hospital Updates

Prof. Raj Kumar of Vallabhbhai Patel Chest Institute Selected for ATS Public Service Award by American Thoracic Society

The American Thoracic Society (ATS) Awards Committee has selected Prof. Raj Kumar, Director of Vallabhbhai Patel Chest Institute (VPCI) for the annual ATS Public Service Award at the ATS 2024 International Conference in San Diego, California. This public service award is given to individuals in the areas related to public and population health equity, improving […]

"PaxMedica Presentation"
Drug Updates

PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments

 PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of its latest company presentation. This comprehensive overview showcases PaxMedica’s strategic direction, recent advancements in ASD therapeutics, and its commitment to addressing unmet needs within the ASD community. Click here to view the presentation. The new presentation, available on […]

A cigarette factory with large stacks emitting smoke.
Hospital Updates

Philip Morris To Open New Cigarette Factory in Tanzania, Showing It Isn’t Serious About Creating a “Smoke-Free Future”

Philip Morris International, the world’s largest publicly traded cigarette company, plans to open a new cigarette factory in Tanzania, according to media reports. The announcement is yet another act of hypocrisy from the tobacco giant that claims it is committed to “delivering a smoke-free future.” You don’t achieve a smoke-free future by building new cigarette factories […]

Yogurt and Type 2 Diabetes
Digital Health News

Danone North America Announces the FDA’s Decision on Their Petition for the First-Ever Qualified Health Claim for Yogurt, Linking This Dairy Aisle Staple to a Reduced Risk of Type 2 Diabetes

 In response to a petition submitted by food and beverage leader Danone North America, the U.S. Food and Drug Administration (FDA) today announced the first-ever qualified health claim for yogurt, recognizing a potential link between its regular consumption and a reduced risk of type 2 diabetes, and giving consumers another compelling reason to shop the yogurt […]

Group of college students studying together.
Hospital Updates

Lost in Time: Alcohol Tax Devaluation Could Rescue California’s State System

Alcohol Justice is calling on California Governor Gavin Newsom to bring the state’s alcohol excise tax into line with modern standards to fund the troubled California State University (CSU) system and other educational priorities. In California, alcohol is taxed at fixed rates per volume produced. This means that the tax has lost 55% of its value due to inflation […]

"SKYTyphoid Vaccine Illustration"
Drug Updates

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced today that the company has obtained prequalification (PQ) certification from the World Health Organization (WHO) for its typhoid conjugate vaccine (TCV), ‘SKYTyphoid®’ (project name NBP618). This the fourth WHO PQ the company has received following its […]

Tetra Pharm Technologies TPT0701: Novel Appetite Suppressant
Drug Updates

Tetra Pharm Technologies Advances CB1 Antagonist TPT0701 for Appetite Suppression into Preclinical Testing

Following the successful filing of the Intellectual Property (IP) for its applied platform technology targeting the endocannabinoid system (ECS), Tetra Pharm Technologies is moving forward with its appetite suppression supplement, TPT0701. Modulation of the endocannabinoid system has long been recognized as a promising way to regulate appetite. Through intensive research and development, Tetra Pharm Technologies […]